NEWS

Lipocine announces positive topline Phase 2 results from LPCN1144 ongoing Lift study in biopsy-confirmed NASH subjects

  • 2021.01.14
  • NEWS RELEASE

Lipocine (USA, UA) announced on 12 January, 2021, positive topline Phase 2 results from LPCN1144 ongoing LiFT study in biopsy-confirmed NASH subjects.

 

For detailed information, see the below URL.

https://www.lipocine.com/news-article/lipocine-announces-positive-topline-phase-2-results-from-lpcn-1144-ongoing-lift-study-in-biopsy-confirmed-nash-subjects/

 

Page back